Evidence map›Paper›PMID 32359218›Full record

ArticleEuropean journal of neurology2020

Tablet-based electroencephalography diagnostics for patients with epilepsy in the West African Republic of Guinea.

E Sokolov, D H Abdoul Bachir, F Sakadi, J Williams, A C Vogel, M Schaekermann, N Tassiou, A K Bah, V Khatri, G C Hotan and 23 more

Open access · greenAbstract read
In one paragraph

Article in European journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. E = mcEpilepsia open · 2024
    Article
  4. Article
  5. Article
  6. The Recent Progress and Applications of Digital Technologies in Healthcare: A Review.International journal of telemedicine and applications · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 17 institutions in 5 countries.

E SokolovDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
D H Abdoul BachirDepartment of Neurology, Ignace Deen Hospital, Conakry, Guinea.
F SakadiDepartment of Neurology, Ignace Deen Hospital, Conakry, Guinea.
J WilliamsDepartment of Neurology, Mater Misericordiae University Hospital and Dublin Neurological Institute, Dublin, Ireland.
A C VogelDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
M SchaekermannUniversity of Waterloo, Waterloo, ON, Canada.
N TassiouDepartment of Neurology, Ignace Deen Hospital, Conakry, Guinea.
A K BahDepartment of Neurology, Ignace Deen Hospital, Conakry, Guinea.
V KhatriDepartment of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
G C HotanDepartment of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Boston, MA, USA.
N AyubDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
E LeungDepartment of Pediatrics, University of Manitoba, Winnipeg, MB, USA.
T A FantaneanuDivision of Neurology, The Ottawa Hospital, Ottawa, ON, Canada.
A PatelHarvard Medical School, Boston, MA, USA.
M VyasDivision of Neurology, University of Toronto, Toronto, ON, USA.
T MilliganDepartment of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
M F VillamarDepartment of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
D HochDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
S PurvesUniversity of British Columbia, Vancouver, BC, Canada.
B EsmaeiliDepartment of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
M StanleyDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
T Lehn-SchiolerDanish Technical University, Copenhagen, Denmark.
J Tellez-ZentenoUniversity of Saskatchewan College of Medicine, Saskatoon, SK, Canada.
E Gonzalez-GiraldoUniversity of California, San Francisco, CA, USA.
I TolokhDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
L HeidarianUniversity of Utah, Salt Lake City, UT, USA.
L WordenChildren's Hospital of Philadelphia, PA, USA.ORCID 0000-0003-2268-0206
N JadejaUniversity of Massachusetts School of Medicine, Boston, MA, USA.
S FridingerChildren's Hospital of Philadelphia, PA, USA.
L LeeSunnybrook Health Sciences Centre, Toronto, ON, Canada.
E LawUniversity of Waterloo, Waterloo, ON, Canada.
C Fodé AbassDepartment of Neurology, Ignace Deen Hospital, Conakry, Guinea.
F J MateenDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-4293-8115
Harvard University · USIgnace Deen Hospital · GNBrigham and Women's Hospital · USChildren's Hospital of Philadelphia · USMassachusetts General Hospital · USUniversity of Waterloo · CABoston Children's Hospital · USInstitute of Cognitive and Brain Sciences · USMater Misericordiae University Hospital · IEOttawa Hospital · CASunnybrook Health Science Centre · CATechnical University of Denmark · DKUniversity of British Columbia · CAUniversity of California, San Francisco · USUniversity of Massachusetts Boston · USUniversity of Saskatchewan · CAUniversity of Utah · US

Funding

CLINICAL UTILITY OF A SMARTPHONE-BASED EEG SYSTEM FOR PEOPLE WITH EPILEPSY IN BHUTANR21NS098886 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MATEEN, FARRAH JASMINE · 2017 to 2018
$396k
Hospital Corporation of America (HCA) International FoundationNINDS NIH HHS R21 NS098886
6 · The paper itself

Abstract

background and purposeEpilepsy is most common in lower-income settings where access to electroencephalography (EEG) is generally poor. A low-cost tablet-based EEG device may be valuable, but the quality and reproducibility of the EEG output are not established.

methodsTablet-based EEG was deployed in a heterogeneous epilepsy cohort in the Republic of Guinea (2018-2019), consisting of a tablet wirelessly connected to a 14-electrode cap. Participants underwent EEG twice (EEG1 and EEG2), separated by a variable time interval. Recordings were scored remotely by experts in clinical neurophysiology as to data quality and clinical utility.

resultsThere were 149 participants (41% female; median age 17.9 years; 66.6% ≤21 years of age; mean seizures per month 5.7 ± SD 15.5). The mean duration of EEG1 was 53 ± 12.3 min and that of EEG2 was 29.6 ± 12.8 min. The mean quality scores of EEG1 and EEG2 were 6.4 [range, 1 (low) to 10 (high); both medians 7.0]. A total of 44 (29.5%) participants had epileptiform discharges (EDs) at EEG1 and 25 (16.8%) had EDs at EEG2. EDs were focal/multifocal (rather than generalized) in 70.1% of EEG1 and 72.5% of EEG2 interpretations. A total of 39 (26.2%) were recommended for neuroimaging after EEG1 and 22 (14.8%) after EEG2. Of participants without EDs at EEG1 (n = 53, 55.8%), seven (13.2%) had EDs at EEG2. Of participants with detectable EDs on EEG1 (n = 23, 24.2%), 12 (52.1%) did not have EDs at EEG2.

conclusionsTablet-based EEG had a reproducible quality level on repeat testing and was useful for the detection of EDs. The incremental yield of a second EEG in this setting was ~13%. The need for neuroimaging access was evident.

Indexed as

EpilepsyAdolescentElectroencephalographyFemaleGuineaHumansMaleReproducibility of ResultsSeizuresAfricadiagnosiselectroencephalographyepilepsyseizuretelemedicine

Identifiers

PMID32359218
PMCPMC8830803
OpenAlexW3022175196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.